India Based Injectables Company Attracts Multiple Global Deals

1
India Based Injectables Company Attracts Multiple
Global Deals
2

• Hyderabad based Gland Pharmaceuticals Ltd is
  attracting investors and buyers from all over the
  world. Global buyout firm Advent International
  and US based Baxter International are ready with
  their deals to invest in Gland Pharma Ltd.

3

• Indian drug maker Torrent Pharmaceuticals is
  expected to be binding bids by the middle of the
  next month. KKR (an American investment firm)
  invested in Gland Pharmaceuticals for the first
  time in 2013 with an amount of about 200
  million.

4

• This investment was the largest private equity of
  the time with the company valued at about 600
  million. Gland Pharma founders and KKR own about
  99 of the company. Both are selling their
  combined stake in this deal that is valued at
  between 1 billion and 1.5 billion.

5
(No Transcript)
6

• Established in 1978, Gland Pharma is a globally
  renowned manufacturer company of Small Volume
  Parenterals (SVPs) with presence in about 90
  countries in five continents.

7

• It was the first company to set up a
  state-of-the-art Pre-Filled Syringes (PFS)
  facility in India and having credit of first
  company to get acceptance by US FDA for liquid
  injectable facility in India.

8

• A world leaders in Glycosaminoglycans (GAGs)
  range of molecules, Gland Pharma is known for
  their pioneer Heparin technology in India. The
  injectables business of Gland Pharma is certainly
  a lucrative opportunity for investors.

9
(No Transcript)
10

• Other giant market players are also investing in
  this potential market. Pfizer acquired US firm
  Hospira for 17 billion last year partly to
  develop its injectable drug business. Mylan NV
  paid 1.6 billion in 2013 to buy the injectables
  drug unit of Indias Strides Arcolabs.

11

• For More Information, Visit Us

http//medgenera.com/